Outset Medical, Inc. Net Income (Loss) Available to Common Stockholders, Diluted
Outset Medical, Inc. (OM) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$30.02 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-06.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2021-05-06
- Outset Medical, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2021-03-31 was -$30.02M, a 821.58% decline year-over-year.
- Outset Medical, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2020-12-31 was -$32.04M.
- Outset Medical, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2020-09-30 was -$42.29M.
- Outset Medical, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2020-06-30 was -$26.50M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|---|
| 2021-03-31 | -$30.02M 10-Q · filed 2021-05-06 | -$62.07M derived: sum of 2 quarters · filed 2021-05-06 | -$104.36M derived: sum of 3 quarters · filed 2021-05-06 | -$130.87M derived: sum of 4 quarters · filed 2021-05-06 |
| 2020-12-31 | -$32.04M 10-K · filed 2021-03-22 | -$74.34M derived: sum of 2 quarters · filed 2021-03-22 | -$100.84M derived: sum of 3 quarters · filed 2021-03-22 | -$96.68M derived: sum of 4 quarters · filed 2021-05-06 |
| 2020-09-30 | -$42.29M 10-K · filed 2021-03-22 | -$68.80M derived: sum of 2 quarters · filed 2021-03-22 | -$64.64M derived: sum of 3 quarters · filed 2021-05-06 | |
| 2020-06-30 | -$26.50M 10-K · filed 2021-03-22 | -$22.34M derived: sum of 2 quarters · filed 2021-05-06 | ||
| 2020-03-31 | $4.16M 10-Q · filed 2021-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |